To view this email as a web page, click here.
 
Vaginal gel shows promise for recurrent BV
Results of a Phase III study suggest that a microbicidal vaginal gel may hold promise for prevention of recurrent bacterial vaginosis (BV).
More
ADVERTISEMENT
 
Do patients tell clinicians about imminent health threats?
image description here Results of a new study that used Amazon’s survey technology reveal whether patients are telling clinicians when they face imminent threats to their health.

More
 
IN CASE YOU MISSED IT
 
Diagnosing rectosigmoid endometriosis
Quiz: Genitourinary syndrome of menopause
 
JOB OPPORTUNITIES
 
IL - Erie Family Health Center
National - OB Hospitalist Group
NJ - TeamHealth
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.